• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES; PROSTHESIS, RIB REPLACEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES; PROSTHESIS, RIB REPLACEMENT Back to Search Results
Catalog Number UNK - VEPTR
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Failure of Implant (1924); Unspecified Infection (1930)
Event Date 10/13/2010
Event Type  Injury  
Manufacturer Narrative
The device was used for treatment, not diagnosis.Mean age 48.6 months; range 15-168 months.8 males, 8 females.Weight not reported.This report is for unknown veptr, unknown part number and unknown lot number.Flynn, j., et al.(2010).Is the vertebral expandable prosthetic titanium rib a surgical alternative in patients with spina bifida? clin orthop relat res (2011) 469:1291¿1296 if information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
This report is being filed after the subsequent review of the following journal article: is the vertebral expandable prosthetic titanium rib a surgical alternative in patients with spina bifida? twenty nonambulatory patients with myelodysplasia were part of a multicenter investigational device exemption study of 214 patients treated with the vertebral expandable prosthetic titanium rib (veptr) system.Sixteen (16) of the 20 patients were analyzed.The average age at first surgery was 48.6 months.Eight (8) patients were male and eight female.The mean age at the initial procedure was 48.6 months (range 15¿168 months).The minimum follow-up was 25 months (mean, 59 months; range, 25¿164 months).Complications directly related to veptr included 12 events.There were five soft tissue superficial wound infections that were treated with nutritional support, local debridement and antibiotics; two deep wound infections requiring removal of the implant; and five implant migrations: two superior migrations of the rib cradle, one superior migration of the rib cradle with a brachial plexus palsy, one migration of the dunn-mccarthy hook, and one fracture of the dunn-mccarthy rod.It was the opinion of the authors that veptr is a reasonable treatment option for spinal deformity in the immature, nonambulatory myelodysplasia population correcting spinal the deformity, allowing spinal growth, and maintaining adequate respiratory function.The rate of complications were within the range reported for spinal fusion using standard approaches.This report is for 7 infections and 3 implant migrations for (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
PROSTHESIS, RIB REPLACEMENT
Manufacturer (Section D)
SYNTHES
1302 wrights lane east
west chester
PA 19380
Manufacturer Contact
linda plews
1302 wrights lane east
west chester, PA 19380
6107195000
MDR Report Key3776204
MDR Text Key21152697
Report Number2520274-2014-11060
Device Sequence Number1
Product Code MDI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
PH030009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Company Representative
Reporter Occupation Health Professional
Type of Report Initial
Report Date 04/03/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue NumberUNK - VEPTR
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/03/2014
Initial Date FDA Received04/28/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-